While the ubiquitous role of Bcl-2 in promoting cell survival is well-established, its precise mechanisms and clinical implications can vary significantly across different cancer types, necessitating a nuanced understanding for effective therapeutic targeting. This evidence concerns the gene BCL2 and cancer.